H. LEON BRADLOW, PH.D.,
DAVID K. FUKUSHIMA, PH.D.,
BARNETT ZUMOFF, M.D.,
LEON HELLMAN, M.D. and
T. F. GALLAGHER, PH.D.
Division of Steroid Metabolism and Biochemistry, Sloan-Kettering Institute for Cancer Research New York, N. Y.
The metabolism of Reichstein's Substance E-4-C14 (110,17,20β,21-tetrahydroxy-4-pregnene-3-one) has been studied in a normal subject. It wasfound that 2 of the principal metabolic reactions, reductionof the 4-3-ketone and oxidation of the 11β- hydroxyl group,occurred with this hormone with a preformed glycerol side chain.No significant amounts of epimerization or oxidation of the20β-hydroxyl group could be detected. The metabolic patternobserved after the administration of this compound was comparedwith that following hydrocortisone in the same subject. Fromthese studies it was concluded that the reduction of the 20-ketogroup is not a major first step in the metabolism of hydrocortisonein normal man.